Health and Healthcare

Thursday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

BIONOVO INC [BNVI.OB] +17.04%
FERMAVIR PHARMACEUTL [FMVR.OB] +11.11%
VERNALIS PLC ADR [VNLS] +9.58%
CHELSEA THERAPEUTICS [CHTP] +6.77%
XTL BIOPHARMACEUTICA [XTLB] +5.77%

Diagnostic Substances

ASPENBIO PHARMA INC [APNB.OB] +4.45%
CYTOGEN CORP [CYTO] +3.50%
DADE BEHRING HLDGS [DADE] +3.40%
TRINITY BIO ADR [TRIB] +3.21%
PRESSURE BIOSCIENC [PBIO] +2.48%

Drug Delivery

NOVADEL PHARMA INC [NVD] +3.12%
QUIGLEY CORP THE [QGLY] +0.89%
PENWEST PHARM CO [PPCO] +0.82%
NOVEN PHARMACEUTIC [NOVN] +0.43%
NEKTAR THERAPEUTIC [NKTR] +0.42%

Drug Manufacturers

YM BIOSCIENCES INC [YMI] +11.05%
RELIV INTL INC [RELV] +8.37%
ACUSPHERE INC [ACUS] +4.74%
DUSA PHARM INC [DUSA] +3.70%
TEVA PHARM INDS AD [TEVA] +3.19%

Medical Appliances & Equipment

MICRUS ENDOVASCULAR [MEND] +6.85%
ENDOCARE INC [ENDO.OB] +6.06%
MEDICALCV INC [MCVI.OB] +5.63%
CRITICARE SYS INC [CMD] +5.43%
VISION SCIENCES IN [VSCI] +3.70%

Medical Instruments & Supplies

MILESTONE SCIENTIFIC [MLSS.OB] +5.92%
EP MEDSYSTEMS INC [EPMD] +4.86%
NEPHROS INC. [NEP] +4.57%
ALPHATEC HOLDINGS [ATEC] +4.42%
HOME DIAGNOSTICS, IN [HDIX] +4.30%

Medical Laboratories & Research

RADNET INC [RDNT.OB] +3.79%
QUEST DIAGNOSTC [DGX] +2.22%
MEDASORB TECHNOLOGS [MSBT.OB] +1.69%
BIO-REFERENCE LAB [BRLI] +0.86%
ERESEARCHTECHNOLOG [ERES] +0.75%

http://www.biohealthinvestor.com/

Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.